MedPath

Prevention of Preterm Birth in Singletons Using Pessary After Resolutive Threatened Preterm Labor

Not Applicable
Completed
Conditions
Preterm Birth
Interventions
Device: Silicone pessary
Registration Number
NCT02484820
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

In France, threatened preterm labour concerns 6.5% of pregnancies and is associated with a premature birth in 25.4% of cases.

After 48 hours effective tocolysis, patients do not receive any further treatment while their risk of premature birth has risen from 6.5% to 25%.

A pessary is a silicone ring encircling the cervix. It was initially used as medical treatment of genital prolapse but studies were also conducted for pregnant women in 2 high-risk premature birth situations: cervical incompetence and twin pregnancies.

The multicenter PECEP trial conducted by Goya and al. in asymptomatic short cervix patients between 18 and 22 weeks of gestation showed a significant reduction of premature birth before 34 and 37 weeks of gestation. Thereby, the investigator assume that use of pessaries in patients presenting a resolutive threatened preterm labor will also be effective.

To evaluate this hypothesis, the investigator designed a randomized prospective single-center open clinical trial comparing pessary associated with standard care (1st group) versus standard care only (2nd group) in patients experiencing an episode of resolutive threatened preterm labor.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
168
Inclusion Criteria
  • Minimal age of 18 years
  • Informed consent
  • Confirmation of dating of pregnancy by first trimester echography.
  • Episode of threatened preterm labour
  • Singleton between 24 and 34 weeks of gestation
  • Cervical length ≤20mm in cervimetry
  • Pulmonary maturation completed
  • ≤6 contractions by hour after 24 hours of tocolysis.
Exclusion Criteria
  • Major fetal abnormalities (requiring surgery or leading to infant death or severe handicap)
  • Spontaneous rupture of membranes at the time of randomization
  • Cervical cerclage in situ
  • Uterus malformations
  • Antecedent of conisation
  • Active vaginal bleeding, placenta previa
  • Intra-amniotic infection
  • Hydramnios
  • Maternal chronic pathology (hypertension, diabetes)
  • Anomaly of breathing foetal rate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PessarySilicone pessarySilicone pessary is associated with standard care Silicone pessary is used between 24 weeks of pregnancy and up to 6 weeks after the date of the term (maximum 6 months)
Primary Outcome Measures
NameTimeMethod
Number of spontaneous delivery37 weeks of gestation

Comparison of the number of spontaneous delivery before 37 completed weeks of gestation for pregnant women after resolutive threatened preterm labour between 20 and 34 weeks of gestation between the 2 groups of the study.

Secondary Outcome Measures
NameTimeMethod
Number of patients with increase of vaginal dischargefrom date of randomization until the date of the delivery

Comparison of the number of patients with increase of vaginal discharge from date of randomization until the date of the delivery between the 2 groups of the study.

Number of patients with neonatal morbidityFrom date of delivery until 6 weeks after the date of term

Number of patient with neonatal morbidity at delivery until 6 weeks after the date of term

Number of patients with spontaneous pessary ejectionfrom date of randomization until the date of the delivery

Comparison of the number of patients with pessary ejection from date of randomization until the date of the delivery between the 2 groups of the study.

Number of spontaneous delivery28 weeks of gestation

Comparison of the number of spontaneous delivery before 28 completed weeks of gestation for pregnant women after resolutive threatened preterm labour between 20 and 34 weeks of gestation between the 2 groups of the study.

Number of admission for preterm laborfrom date of randomization until the date of the delivery

Comparison of the number of admission for preterm labor from date of randomization until the date of the delivery between the 2 groups.

Number of fetal-neonatal deathat delivery

Number of fetal-neonatal death at delivery

Number of birth deathFrom date of delivery until 6 weeks after the date of term

Number of birth death at delivery until 6 weeks after the date of term

Number of patients with discomfortfrom date of randomization until the date of the delivery

Comparison of the number of patients with discomfort from date of randomization until the date of the delivery between the 2 groups of the study. The discomfort is measure by a standardized questionnaire.

number of day between resolutive threatened preterm labor and deliveryAt delivery

Comparison of number of day between the two groups of the study

Trial Locations

Locations (1)

Chu Saint-Etienne

🇫🇷

Saint-Etienne, France

© Copyright 2025. All Rights Reserved by MedPath